ÖÐÎÄÃû³Æ£ºCBFA2T2¿¹Ô£¨ÖØ×éµ°°×£©
Ó¢ÎÄÃû³Æ£º CBFA2T2 Antigen (Recombinant Protein)
±ð Ãû£º EHT; p85; MTGR1; ZMYND3
´¢ ´æ£º Àä¶³£¨-20¡æ£©
Ïà¹ØÀà±ð£º ¿¹Ô
¸Å Êö£º
|
Fusion protein corresponding to a region derived from 405-604 amino acids of human CBFA2T2 |
|
Full name: |
CBFA2/RUNX1 translocation partner 2 |
|
Synonyms: |
EHT; p85; MTGR1; ZMYND3 |
|
Swissprot: |
O43439 |
|
Gene Accession: |
BC040344 |
|
Purity: |
>85%, as determined by Coomassie blue stained SDS-PAGE |
|
Expression system: |
Escherichia coli |
|
Tags: |
His tag C-Terminus, GST tag N-Terminus |
|
Background: |
In acute myeloid leukemia, especially in the M2 subtype, the t(8;21)(q22;q22) translocation is one of the most frequent karyotypic abnormalities. The translocation produces a chimeric gene made up of the 5'-region of the RUNX1 (AML1) gene fused to the 3'-region of the CBFA2T1 (MTG8) gene. The chimeric protein is thought to associate with the nuclear corepressor/histone deacetylase complex to block hematopoietic differentiation. The protein encoded by this gene binds to the AML1-MTG8 complex and may be important in promoting leukemogenesis. Several transcript variants are thought to exist for this gene, but the full-length natures of only three have been described. |
¹ºÎï³µ
°ïÖú
021-54845833/15800441009
